Erectile Dysfunction Global Market Report 2025

Description

Erectile dysfunction (ED) is the inability to achieve or sustain an erection adequate for satisfactory sexual performance. It is a prevalent condition influenced by physical, psychological, and lifestyle factors, impacting men's overall well-being and quality of life.

The primary product categories for erectile dysfunction include drugs and devices. Drugs are chemical formulations designed to improve blood flow to the penis, enabling men to attain and maintain an erection. These products are distributed through hospital pharmacies, retail pharmacies, and online channels, serving end users such as hospitals and clinics, ambulatory surgery centers, pharmacies, and other healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The erectile dysfunction market research report is one of a series of new reports from The Business Research Company that provides erectile dysfunction market statistics, including erectile dysfunction industry global market size, regional shares, competitors with an erectile dysfunction market share, detailed erectile dysfunction market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction industry. This erectile dysfunction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The erectile dysfunction market size has grown strongly in recent years. It will grow from $2.46 billion in 2024 to $2.68 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to the rising incidence of cardiovascular diseases, increasing prevalence of diabetes, growing awareness of erectile dysfunction as a medical condition, an aging population leading to higher erectile dysfunction cases, and rising preference for personalized treatment options.

The erectile dysfunction market size is expected to see strong growth in the next few years. It will grow to $3.75 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to an increase in psychological factors, higher rates of obesity and metabolic disorders, growing demand for non-invasive erectile dysfunction treatments, an increase in patient consultations for sexual health, and increasing government initiatives to promote men's health and lifestyle-related risk factors. Major trends in the forecast period include the expansion of e-pharmacies for erectile dysfunction drugs, advancements in penile implant technologies, technological advancements in erectile dysfunction diagnostics, innovative treatment methods targeting root causes of erectile dysfunction, and the introduction of effective phosphodiesterase type 5 inhibitors.

The forecast of 8.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of ED therapies by inflating prices of PDE5 inhibitors and penile implant components developed in India and Ireland, resulting in reduced treatment accessibility and higher urology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of lifestyle-related diseases is expected to drive growth in the erectile dysfunction market. Lifestyle-related diseases are primarily caused by unhealthy habits such as poor diet, lack of physical activity, smoking, and excessive alcohol consumption. Factors contributing to the rise in these conditions include increased sedentary behavior, poor dietary choices, stress, and unhealthy habits. Erectile dysfunction (ED) is often an early indicator of lifestyle-related diseases, including cardiovascular conditions and diabetes, emphasizing the importance of timely medical intervention and healthier lifestyle changes. For example, in May 2022, the World Obesity Federation, a UK-based non-profit organization, reported that by 2030, one billion people worldwide equivalent to one in five women and one in seven men are projected to be living with obesity. This figure is expected to rise to four billion people, or 51% of the global population, who will be either overweight or obese by 2035. The increasing prevalence of lifestyle-related diseases is, therefore, expected to drive the growth of the erectile dysfunction market.

Leading companies in the erectile dysfunction market are focusing on developing innovative products, such as over-the-counter (OTC) gels, to provide more accessible and convenient treatment options for individuals with ED. This approach aims to expand market reach and address unmet patient needs. An OTC gel is a topical medication available without a prescription, applied directly to the skin to treat specific conditions. For instance, in September 2024, Haleon plc, a UK-based consumer healthcare company, introduced Eroxon, the first FDA-cleared over-the-counter gel for erectile dysfunction. This groundbreaking product offers a non-invasive, fast-acting solution designed to improve accessibility and convenience for patients. Its topical application eliminates the need for oral medications, reducing potential systemic side effects and providing an alternative treatment option.

In September 2022, Advanced MedTech Holdings, a Singapore-based medical device company, acquired Shenzhen Wikkon Medical Apparatus Co. Ltd. for an undisclosed amount. This acquisition strengthens Advanced MedTech Holdings' presence in the urology sector in China by leveraging Wikkon's expertise in developing and manufacturing urology and shock wave therapy devices. Shenzhen Wikkon Medical Apparatus Co. Ltd., a China-based company, specializes in extracorporeal shock wave therapy (ESWT) for treating conditions such as erectile dysfunction and urinary stones.

Major players in the erectile dysfunction market are Pfizer Inc., Bayer AG, Dong-A Socio Holdings Co. Ltd., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Limited, Boston Scientific Corporation, Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Coloplast Corporation, Dr. Reddy's Laboratories Limited, Cipla Limited, Ferring Pharmaceuticals A/S, Endo International plc, Zydus Lifesciences Limited, Lupin Limited, Hims & Hers Health Inc., Cadila Pharmaceuticals Limited, VIVUS Inc., Rigicon Inc., Petros Pharmaceuticals Inc., Futura Medical plc, Apricus Biosciences Inc., Pos-T-Vac Medical Inc., Initiator Pharma A/S.

North America was the largest region in the erectile dysfunction market in 2024. The regions covered in erectile dysfunction report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the erectile dysfunction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The erectile dysfunction market consists of sales of medications, devices, and therapies aimed at treating erectile dysfunction. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Erectile Dysfunction Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on erectile dysfunction market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for erectile dysfunction ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The erectile dysfunction market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Drugs; Devices
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Channels
3) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Pharmacies; Other End Users
Subsegments:
1) By Drugs: Phosphodiesterase Type 5 (PDE5) Inhibitors; Hormone Therapy; Injectable Medications; Topical Medications
2) By Devices: Vacuum Erection Devices (VEDs); Penile Implants; Shockwave Therapy Devices
Companies Mentioned: Pfizer Inc.; Bayer AG; Dong-A Socio Holdings Co. Ltd.; Sanofi S.A.; GlaxoSmithKline plc; Eli Lilly and Company; Viatris Inc.; Teva Pharmaceutical Industries Limited; Boston Scientific Corporation; Sandoz International GmbH; Sun Pharmaceutical Industries Limited; Coloplast Corporation; Dr. Reddy's Laboratories Limited; Cipla Limited; Ferring Pharmaceuticals A/S; Endo International plc; Zydus Lifesciences Limited; Lupin Limited; Hims & Hers Health Inc.; Cadila Pharmaceuticals Limited; VIVUS Inc.; Rigicon Inc.; Petros Pharmaceuticals Inc.; Futura Medical plc; Apricus Biosciences Inc.; Pos-T-Vac Medical Inc.; Initiator Pharma A/S
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34051u

1. Executive Summary

2. Erectile Dysfunction Market Characteristics

3. Erectile Dysfunction Market Trends And Strategies

4. Erectile Dysfunction Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Erectile Dysfunction Growth Analysis And Strategic Analysis Framework

5.1. Global Erectile Dysfunction PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Erectile Dysfunction Market Growth Rate Analysis
5.4. Global Erectile Dysfunction Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Erectile Dysfunction Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Erectile Dysfunction Total Addressable Market (TAM)

6. Erectile Dysfunction Market Segmentation

6.1. Global Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drugs
Devices
6.2. Global Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Channels
6.3. Global Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Surgery Centers
Pharmacies
Other End Users
6.4. Global Erectile Dysfunction Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phosphodiesterase Type 5 (PDE5) Inhibitors
Hormone Therapy
Injectable Medications
Topical Medications
6.5. Global Erectile Dysfunction Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vacuum Erection Devices (VEDs)
Penile Implants
Shockwave Therapy Devices

7. Erectile Dysfunction Market Regional And Country Analysis

7.1. Global Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Erectile Dysfunction Market

8.1. Asia-Pacific Erectile Dysfunction Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Erectile Dysfunction Market

9.1. China Erectile Dysfunction Market Overview
9.2. China Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Erectile Dysfunction Market

10.1. India Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Erectile Dysfunction Market

11.1. Japan Erectile Dysfunction Market Overview
11.2. Japan Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Erectile Dysfunction Market

12.1. Australia Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Erectile Dysfunction Market

13.1. Indonesia Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Erectile Dysfunction Market

14.1. South Korea Erectile Dysfunction Market Overview
14.2. South Korea Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Erectile Dysfunction Market

15.1. Western Europe Erectile Dysfunction Market Overview
15.2. Western Europe Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Erectile Dysfunction Market

16.1. UK Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Erectile Dysfunction Market

17.1. Germany Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Erectile Dysfunction Market

18.1. France Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Erectile Dysfunction Market

19.1. Italy Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Erectile Dysfunction Market

20.1. Spain Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Erectile Dysfunction Market

21.1. Eastern Europe Erectile Dysfunction Market Overview
21.2. Eastern Europe Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Erectile Dysfunction Market

22.1. Russia Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Erectile Dysfunction Market

23.1. North America Erectile Dysfunction Market Overview
23.2. North America Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Erectile Dysfunction Market

24.1. USA Erectile Dysfunction Market Overview
24.2. USA Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Erectile Dysfunction Market

25.1. Canada Erectile Dysfunction Market Overview
25.2. Canada Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Erectile Dysfunction Market

26.1. South America Erectile Dysfunction Market Overview
26.2. South America Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Erectile Dysfunction Market

27.1. Brazil Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Erectile Dysfunction Market

28.1. Middle East Erectile Dysfunction Market Overview
28.2. Middle East Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Erectile Dysfunction Market

29.1. Africa Erectile Dysfunction Market Overview
29.2. Africa Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Erectile Dysfunction Market Competitive Landscape And Company Profiles

30.1. Erectile Dysfunction Market Competitive Landscape
30.2. Erectile Dysfunction Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Dong-A Socio Holdings Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Erectile Dysfunction Market Other Major And Innovative Companies

31.1. Eli Lilly and Company
31.2. Viatris Inc.
31.3. Teva Pharmaceutical Industries Limited
31.4. Boston Scientific Corporation
31.5. Sandoz International GmbH
31.6. Sun Pharmaceutical Industries Limited
31.7. Coloplast Corporation
31.8. Dr. Reddy's Laboratories Limited
31.9. Cipla Limited
31.10. Ferring Pharmaceuticals A/S
31.11. Endo International plc
31.12. Zydus Lifesciences Limited
31.13. Lupin Limited
31.14. Hims & Hers Health Inc.
31.15. Cadila Pharmaceuticals Limited

32. Global Erectile Dysfunction Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Erectile Dysfunction Market

34. Recent Developments In The Erectile Dysfunction Market

35. Erectile Dysfunction Market High Potential Countries, Segments and Strategies

35.1 Erectile Dysfunction Market In 2029 - Countries Offering Most New Opportunities
35.2 Erectile Dysfunction Market In 2029 - Segments Offering Most New Opportunities
35.3 Erectile Dysfunction Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer